https://www.forbes.com/sites/russellflannery/2023/09/20/fundamentally-wrong-less-than-5-of-cancer-patients-get-access-to-clinical-trials/
Long R&D time-line is "unacceptable," says Memorial Sloan Kettering cancer specialist Bob Li
Create an account
or login to join the discussion